For This Week in Cardiology September 23, 2016, Dr John Mandrola comments on the following cardiology news and features stories:
Evolocumab Slows Coronary Plaque Growth by IVUS: Top-line Results
Hypotension No Reason to Avoid Sacubitril/Valsartan, Says PARADIGM-HF
Digoxin for HF Ups Rehospitalizations in Cohort, Survival Not Affected
Catching Medication Errors: The HF-Clinic Pharmacist Is on the Phone
Statin Safety Claims in Lancet Reignite Acrimony, Scientific Divide
Related References:
Chief Cardiology Correspondent
John M Mandrola, MD, Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky
John M Mandrola, MD has disclosed the following relevant financial relationships:
Served as a speaker or member of a speaker's bureau for Medtronic.
© 2016 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Sep 23 Cardiology News Podcast - Medscape - Sep 23, 2016.
Comments